Radiation Oncology/Therapy: Page 93

Proton therapy: Is randomization needed?
By Tami Freeman, PhD
Are randomized clinical trials appropriate for demonstrating proton therapy's superiority to x-ray therapy? The European Society for Therapeutic Radiology and Oncology meeting, held last month in London, was the venue of a contentious debate on this subject.
June 8, 2011
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Brainlab to buy Voyant Health
By AuntMinnieEurope.com staff writers
Image-guided therapy firm Brainlab has entered into an agreement to acquire Voyant Health, an orthopedics imaging informatics company based in Tel Aviv.
June 6, 2011
Philips partners with charity on Moscow pediatric unit
By AuntMinnieEurope.com staff writers
Philips Healthcare is partnering with the cancer charity the Grant Life Foundation to provide imaging technology to a new Children's Oncology complex in Moscow, which opened yesterday.
June 1, 2011
Elekta signs distributor deal with ScandiDos
By AuntMinnieEurope.com staff writers
Oncology firm Elekta has entered into a nonexclusive distribution agreement to sell the Delta4PT pretreatment verification system from ScandiDos.
May 29, 2011
IORT boost yields improved long-term breast tumor control
By Becky McCall
Intraoperative radiotherapy (IORT) administered as a boost during breast surgery provides outstanding tumor control outcomes compared to a conventional boost, attendees were told at the European Society for Therapeutic Radiology and Oncology meeting earlier this month in London.
May 22, 2011
RTOG announces glioblastoma trial results
By Cynthia E. Keen
A trial comparing two chemotherapy doses combined with radiotherapy showed equivocal results for glioblastoma. However, it did prove the feasibility of collecting and analyzing tumor tissue prospectively in an international, multicenter setting, the Radiation Therapy Oncology Group (RTOG) announced.
May 19, 2011
Oraya completes clinical trial enrollment
By AuntMinnieEurope.com staff writers
Oraya Therapeutics has completed enrollment of its INTREPID (IRay plus anti-VEGF Treatment for Patients with Wet Age-related Macular Degeneration) clinical trial in Europe.
May 18, 2011
PET enables better monitoring of intratumoral changes
By Becky McCall
Growing use of hypofractionation in clinical practice and its link to increased treatment resistance due to tumor cell hypoxia means that it may be beneficial to visualize and quantify hypoxic areas with PET imaging to monitor changes in tumor metabolism during treatment.
May 18, 2011
2011 05 19 11 21 20 441 Bussink Thumb
ViewRay nets U.S., European patents
By AuntMinnieEurope.com staff writers
Image-guided therapy developer ViewRay has been awarded patents in the U.S. and Europe for its combined MRI and radiation therapy technologies.
May 18, 2011
IsoRay nets revenue gain in Q3
By AuntMinnieEurope.com staff writers
A 21% increase in patient cases helped medical isotope developer IsoRay Medical to a third-quarter revenue gain and a lower net loss compared to the same quarter of the prior year.
May 16, 2011
IBA revenues increase by 20% in Q1
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) reported nearly 20% revenue growth in its first quarter.
May 11, 2011
PET/CT helps target radiation therapy of NSCLC tumors
By Becky McCall
LONDON - PET/CT prior to radiotherapy can help oncologists target a more powerful dose of radiation to non-small cell lung cancer (NSCLC), whilst keeping dose low in other areas of the organ, according to research presented at this week's European Society for Therapeutic Radiology and Oncology meeting.
May 10, 2011
2011 05 11 14 00 56 747 Estro Clinical 394
Previous Page
Page 93 of 127
Next Page